A toolbox for studying the transcriptional diversity and functions of human microglia in vitro

No authors listed

Comment

No authors listed. Nat Immunol. 2023 Aug.

. 2023 Aug;24(8):1226-1227.

doi: 10.1038/s41590-023-01570-6.

No abstract available

Comment on

Exposure of iPSC-derived human microglia to brain substrates enables the generation and manipulation of diverse transcriptional states in vitro.
Dolan MJ, Therrien M, Jereb S, Kamath T, Gazestani V, Atkeson T, Marsh SE, Goeva A, Lojek NM, Murphy S, White CM, Joung J, Liu B, Limone F, Eggan K, Hacohen N, Bernstein BE, Glass CK, Leinonen V, Blurton-Jones M, Zhang F, Epstein CB, Macosko EZ, Stevens B. Dolan MJ, et al. Nat Immunol. 2023 Aug;24(8):1382-1390. doi: 10.1038/s41590-023-01558-2. Epub 2023 Jul 27. Nat Immunol. 2023. PMID: 37500887 Free PMC article.

1. Hammond, T. R. et al. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity 50, 253–271.e6 (2019). This is one of the articles reporting multiple microglia states in mice across development and aging. - DOI - PubMed
1. Paolicelli, R. C. et al. Microglia states and nomenclature: a field at its crossroads. Neuron 110, 3458–3483 (2022). This review article discusses the challenges of and upcoming questions about microglial states. - DOI - PubMed - PMC
1. Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer’s disease. Cell 169, 1276–1290.e17 (2017). This paper first identified DAM signatures in patients with AD and in an AD mouse model. - DOI - PubMed
1. Abud, E. M. et al. iPSC-derived human microglia-like cells to study neurological diseases. Neuron 94, 278–293.e9 (2017). This is one of the first iMGL-differentiation protocols published. - DOI - PubMed - PMC